05.02.26 -- Drug Delivery Leader Best Of April

During a Drug Delivery Leader Live event, Chief Editor Tom von Gunden relays an audience question on when injection volume should drive the choice between prefilled syringes and autoinjectors.

In an episode of In Combination, patients share how switching from IV to subcutaneous therapy transformed their lives, with added insight from Halozyme CMO Charles Theuer.

Tom von Gunden examines how AI analysis of regulatory precedents can strengthen drug delivery submissions, with insight from consultant Doug Mead.

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.

Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.